Additional file of Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer

Authors :: Zoeller, Jason J.
Vagodny, Aleksandr
Daniels, Veerle W.
Taneja, Krishan
Tan, Benjamin Y.
DeRose, Yoko S.
Maihi Fujita
Welm, Alana L.
Letai, Anthony
Leverson, Joel D.
Blot, Vincent
Bronson, Roderick T.
Dillon, Deborah A.
Brugge, Joan S.
Publication Year :: 2021
Publisher :: figshare, 2021.
Abstract: Additional file of Navitoclax enhances the effectiveness of EGFR-targeted antibody-drug conjugates in PDX models of EGFR-expressing triple-negative breast cancer

Full Text Access

Tools